Evidence map›Paper›PMID 34339039›Full record

ArticleInfection2021

Establishment of an interdisciplinary board for bone and joint infections.

Christina Otto-Lambertz, Ayla Yagdiran, Kirsten Schmidt-Hellerau, Charlotte Meyer-Schwickerath, Peer Eysel, Norma Jung

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Christina Otto-LambertzDepartment of Orthopedics and Trauma Surgery, Medical Faculty, University Hospital of Cologne, University of Cologne, Cologne, Germany. christina.otto-lambertz@uk-koeln.de.ORCID http://orcid.org/0000-0003-4083-7078
Ayla YagdiranDepartment of Orthopedics and Trauma Surgery, Medical Faculty, University Hospital of Cologne, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0002-1723-5995
Kirsten Schmidt-HellerauDepartment I of Internal Medicine, Medical Faculty, University Hospital of Cologne, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0003-4426-9565
Charlotte Meyer-SchwickerathDepartment I of Internal Medicine, Medical Faculty, University Hospital of Cologne, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0001-6711-6516
Peer EyselDepartment of Orthopedics and Trauma Surgery, Medical Faculty, University Hospital of Cologne, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0002-9929-3370
Norma JungDepartment I of Internal Medicine, Medical Faculty, University Hospital of Cologne, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0002-5740-0772

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe incidence of bone and joint infections is increasing while their treatment remains a challenge. Although guidelines and recommendations exist, evidence is often lacking and treatment complicated by complex clinical presentations and therapeutic options. Interdisciplinary boards shown to improve management of other diseases, seem potentially helpful. We describe the establishment of an osteomyelitis board to show the existing demand for such a platform.

methodsAll patients discussed in the board for bone and joint infections between October 2014 and September 2020 were included in this retrospective study. Data were extracted from patient records and analyzed descriptively.

resultsA total of 851 requests related to 563 patients were discussed in the board during the study period. After a run-in period of 3 years, a stable number of cases (> 170/year) were discussed, submitted by nearly all hospital departments (22 of 25). Recommendations were mainly related to antibiotic treatment (43%) and to diagnostics (24%). Periprosthetic joint infections were the most frequent entity (33%), followed by native vertebral osteomyelitis and other osteomyelitis. In 3% of requests, suspected infection could be excluded, in 7% further diagnostics were recommended to confirm or rule out infection.

conclusionsA multidisciplinary board for bone and joint infections was successfully established, potentially serving as a template for further boards. Recommendations were mainly related to antibiotic treatment and further diagnostics, highlighting the need for interdisciplinary discussion to individualize and optimize treatment plans based on guidelines. Further research in needed to evaluate impact on morbidity, mortality and costs.

Indexed as

Arthritis, InfectiousOsteomyelitisAnti-Bacterial AgentsHumansRetrospective StudiesAnti-Bacterial AgentsBone and joint infectionForeign material-associated infectionInterdisciplinary boardOsteomyelitisPeriprosthetic joint infectionVertebral osteomyelitis

Identifiers

PMID34339039
PMCPMC8613086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.